Trastuzumab is a precise treatment for a certain breast cancer, like a key made for one lock on a cell. A biosimilar is not a generic; we must prove it matches the original medicine in every tiny, complex detail, not just the chemical formula. We review stacks of data, from the lab to the clinic, to ensure no difference in safety or strength. This reminds me of my Rajamudi rice: two farmers may grow the same traditional seed, but the taste and yield depend entirely on the soil and the care—the process is everything. My daughter explains her software testing with the same rigorous patience.
#athletics#track-and-field
Jump in to reply — no account needed.